BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19221420)

  • 1. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
    Schroeder A; Fahrenholz F; Schmitt U
    J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice.
    Schmitt U; Hiemke C; Fahrenholz F; Schroeder A
    Behav Brain Res; 2006 Dec; 175(2):278-84. PubMed ID: 17014917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
    Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
    Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
    Postina R; Schroeder A; Dewachter I; Bohl J; Schmitt U; Kojro E; Prinzen C; Endres K; Hiemke C; Blessing M; Flamez P; Dequenne A; Godaux E; van Leuven F; Fahrenholz F
    J Clin Invest; 2004 May; 113(10):1456-64. PubMed ID: 15146243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
    Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
    FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
    Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
    FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.
    Prinzen C; Trümbach D; Wurst W; Endres K; Postina R; Fahrenholz F
    BMC Genomics; 2009 Feb; 10():66. PubMed ID: 19196476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
    Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
    Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
    Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
    J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.
    Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M
    J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of βsheet blocking peptide H102 on APP metabolic enzymes in hippocampal brain of double transgenic AD mice].
    Jiang F; Sun FX; Xu SM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):299-303. PubMed ID: 29926633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the anti-amyloidogenic secretase ADAM10 in shedding the APP-like proteins.
    Endres K; Fahrenholz F
    Curr Alzheimer Res; 2012 Feb; 9(2):157-64. PubMed ID: 21605036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons.
    Mei Z; Situ B; Tan X; Zheng S; Zhang F; Yan P; Liu P
    Brain Res; 2010 Aug; 1348():165-73. PubMed ID: 20595051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
    Li B; Yu D; Xu Z
    Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
    Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
    Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
    Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
    Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
    Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
    PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.